Dark

TNXP
Tonix Pharmaceuticals Holding Corp.
stock NASDAQ

At Close

Mar 10, 2026 3:59:46 PM EDT

14.16USD+1.578%(+0.22)272,902

14.14Bid 14.17Ask 0.03Spread

Pre-market

Mar 10, 2026 9:28:30 AM EDT

13.76USD-1.291%(-0.18)7,937

After-hours

Mar 10, 2026 4:39:30 PM EDT

13.86USD-2.119%(-0.30)2,987

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

180.63M

CEO

Seth Lederman

Headquarters

New York, USA

Industry

Biotechnology

Next Earnings

Mar 17, 2026 (7d)

Last Split

Feb 5, 20251for100reverse

ARQL SUPN PRGO AGRX XLV

TNXP Stats

Avg. Vol. 10 Day

318,348

Avg. Vol. 30 Day

340,846

Employees

Market Cap

180,631,475

Shares Out.

12,788,069

On/Off Exchange

50%/50%

6 Month Beta

2.07

1 Year Beta

1.23

2 Year Beta

1.15

3 Year Beta

1.09

52 Week Low

12.35

52 Week High

69.97

SMA50

15.85

SMA200

26.16

1 Week

+1.33%

1 Month

-11.22%

3 Month

-28.48%

6 Month

-47.67%

1 Year

+4.86%

2 Year

-98.78%

5 Year

-100.00%

Profile

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.

TNXP Stock Summary

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock price today is $14.16, and today's volume is 272,902. TNXP is up 1.578% today. The 30 day average volume is 340,846. TNXP market cap is 180.63M with 12,788,069 shares outstanding.